Form 8-K - Current report:
SEC Accession No. 0001104659-25-001665
Filing Date
2025-01-07
Accepted
2025-01-07 16:05:27
Documents
22
Period of Report
2025-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2432042d4_8k.htm   iXBRL 8-K 36450
2 EXHIBIT 4.1 tm2432042d4_ex4-1.htm EX-4.1 156165
3 EXHIBIT 4.2 tm2432042d4_ex4-2.htm EX-4.2 128411
4 EXHIBIT 10.1 tm2432042d4_ex10-1.htm EX-10.1 305344
5 EXHIBIT 99.1 tm2432042d4_ex99-1.htm EX-99.1 18743
6 EXHIBIT 99.2 tm2432042d4_ex99-2.htm EX-99.2 16486
10 GRAPHIC tm2432042d4_ex99-1img001.jpg GRAPHIC 2331
11 GRAPHIC tm2432042d4_ex99-2img008.jpg GRAPHIC 7091
12 GRAPHIC tm2432042d4_ex99-2img009.jpg GRAPHIC 7091
13 GRAPHIC tm2432042d4_ex99-2img010.jpg GRAPHIC 7091
  Complete submission text file 0001104659-25-001665.txt   1016531

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA aeon-20250106.xsd EX-101.SCH 3030
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeon-20250106_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeon-20250106_pre.xml EX-101.PRE 22369
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2432042d4_8k_htm.xml XML 3807
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 25514893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)